共 4 条
[1]
Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial[J] . Paul Schoenhagen,E Murat Tuzcu,Carolyn Apperson-Hansen,Chaohui Wang,Kathy Wolski,Songhua Lin,Ilke Sipahi,Stephen J. Nicholls,William A. Magyar,Aaron Loyd,Tammy Churchill,Tim Crowe,Steven E. Nissen.Circulation . 2006 (24)
[2]
A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial[J] . Thomas A. Pearson,Margo A. Denke,Patrick E. McBride,Wendy P. Battisti,William E. Brady,Joanne Palmisano.Mayo Clinic Proceedings . 2005 (5)
[3]
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial[J] . The Lancet . 2002 (9326)
[4]
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies[J] . Harold E Bays,Paul B Moore,Margaret A Drehobl,Sidney Rosenblatt,Phillip D Toth,Carlos A Dujovne,Robert H Knopp,Leslie J Lipka,Alexandre P LeBeaut,Bo Yang,Lillian E Mellars,Cynthia Cuffie-Jackson,Enrico P Veltri.Clinical Therapeutics . 2001 (8)